ADMA 241220 21.00P (ADMA241220P21000) Stock Options, News & Quotes

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US OptionsDetailed Quotes

ADMA241220P21000

Watchlist

3.27
+0.05+1.55%

15min DelayClose Dec 20 16:00 ET

3.29High3.20Low

Intraday

5D
Daily

News

ADMA Biologics Announces Partial Paydown of Senior Term Loan Credit Facility
ADMA BiologicsDec 20 00:00 ET
4 Biotech Stocks Most Wall Street Analysts Are Bullish About
Zacks Dec 19 12:30 ET
Mizuho Securities Maintains ADMA Biologics(ADMA.US) With Buy Rating, Announces Target Price $28
Moomoo NewsDec 17 12:32 ET · Ratings
Express News | ADMA Biologics Inc : Mizuho Raises Target Price to $28 From $24
ReutersDec 17 06:38 ET
ADMA Stock Falls 19% From Its 52-Week High: Should You Buy the Dip?
Zacks Dec 10 12:30 ET
Looking Into ADMA Biologics's Recent Short Interest
BenzingaDec 5 13:30 ET

Comments

sharphooks

Dec 2 09:41

$ADMA Biologics (ADMA.US)$ strange drop. Any negative news?

sharphooks

Nov 20 16:28

$ADMA Biologics (ADMA.US)$ woohoo

Krezash

Nov 8 04:03

$ADMA Biologics (ADMA.US)$ as expected, they smashed their earnings again 💵🔥

Krezash

Nov 1 05:05

Here we goooo

$ADMA Biologics (ADMA.US)$ getting one of the Big 4 to audit them and having their earnings in 7 days, this is going to shoot up in the next week 🚀

Krezash

Oct 31 20:23

$ADMA Biologics (ADMA.US)$ ADMA Biologics, Inc. (NASDAQ:ADMA), a biopharmaceutical company, announced on Thursday that it has appointed KPMG LLP as its new independent registered public accounting firm. The engagement with KPMG is effective immediately following the filing of ADMA's Quarterly Report for the fiscal quarter ended September 30, 2024.